Exploration of a F(ab′)2 Fragment as the Targeting Agent of α-Radiation Therapy: A Comparison of the Therapeutic Benefit of Intraperitoneal and Intravenous Administered Radioimmunotherapy-Reference-Cited by-同舟云学术

Exploration of a F(ab′)2 Fragment as the Targeting Agent of α-Radiation Therapy: A Comparison of the Therapeutic Benefit of Intraperitoneal and Intravenous Administered Radioimmunotherapy

Published:2018-06 Issue:5 Volume:33 Page:182-193
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Milenic Diane E.¹,Kim Young-Seung¹,Baidoo Kwamena E.¹,Wong Karen J.²,Barkley Rachel¹,Delgado Jose¹,Brechbiel Martin W.¹

Affiliation:

1. Radioimmune and Inorganic Chemistry Section, Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

2. Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2018.2434

Reference51 articles.

1. Methodology for labeling proteins and peptides with lead-212 (212Pb)

2. Targeted α-therapy: past, present, future?

3. Pharmacokinetics and Imaging of212Pb-TCMC-Trastuzumab After Intraperitoneal Administration in Ovarian Cancer Patients

4. Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab

5. Dose Escalation and Dosimetry of First-in-Human α Radioimmunotherapy with 212Pb-TCMC-Trastuzumab

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining Cisplatin with Different Radiation Qualities—Interpretation of Cytotoxic Effects In Vitro by Isobolographic Analysis;Pharmaceuticals;2023-12-12

2. A Novel Single-Step-Labeled 212Pb-CaCO3 Microparticle for Internal Alpha Therapy: Preparation, Stability, and Preclinical Data from Mice;Materials;2021-11-23

3. Nanoradiopharmaceuticals Based on Alpha Emitters: Recent Developments for Medical Applications;Pharmaceutics;2021-07-23

4. Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The “Hopeful Eight”;Pharmaceutics;2021-06-18

5. Perspectives on metals-based radioimmunotherapy (RIT): moving forward;Theranostics;2021